文献详情 / 已收录文献
积分0
注册
Scihuhuan 已收录该文献的检索结果

Anti-tumor efficacy study of the Bruton's tyrosine kinase (BTK) inhibitor, ONO/GS-4059, in combination with the glycoengineered type II anti-CD20 monoclonal antibody obinutuzumab (GA101) demonstrates superiorin vivoefficacy compared to ONO/GS-4059 in combination with rituximab

查看该文献的作者、期刊、发表年份与 DOI 信息,并通过平台检索入口继续获取文献。

文献信息

已复制